{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:26:04Z","timestamp":1784168764620,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Department of Guangxi Zhuang Autonomous Foundation of Guangxi Key Research and Development Program","award":["No. GuikeAB16380228"],"award-info":[{"award-number":["No. GuikeAB16380228"]}]},{"name":"the Science and Technology Department of Guangxi Zhuang Autonomous Foundation of Guangxi Key Research and Development Program","award":["No. GuikeAB20238025"],"award-info":[{"award-number":["No. GuikeAB20238025"]}]},{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC81760010"],"award-info":[{"award-number":["NSFC81760010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We investigated the clinical features and screened for predictive factors of anti-interferon-\u03b3 autoantibody (AIGA) positivity. We enrolled 63 AIGA-positive (group 1) and 29 AIGA-negative (group 2) HIV-negative patients. White blood cell (WBC) and neutrophil counts, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), globulin, immunoglobulin (Ig) G, and IgM levels were higher, whereas CD4<jats:sup>+<\/jats:sup>T cell count and hemoglobin level were lower in group 1 than in group 2. Co-infections, multiple infections, and disseminated infections were significantly higher in group 1 than in group 2. Prognosis was worse in group 1 than in group 2, especially for relapse and persistent infections. The number of infecting pathogens and sites involved; WBC and neutrophil counts; globulin, IgG, IgM, and CRP levels; and ESR were significantly positively correlated with AIGA titers; however, CD4<jats:sup>+<\/jats:sup>T cell count was significantly negatively correlated with AIGA titers. Therefore, IgG, globulin, and CRP levels; CD4<jats:sup>+<\/jats:sup>T cell and WBC counts; the number of infecting pathogens and sites involved; and ESR were considered potential predictors for AIGA positivity. For HIV-negative hosts with double or multiple opportunistic, disseminated infections and high serum IgG and globulin levels, low CD4<jats:sup>+<\/jats:sup>T cell count, and an increase in inflammatory marker levels, positive AIGA-associated immunodeficiency should be considered.<\/jats:p>","DOI":"10.1038\/s41598-022-13160-x","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T15:06:00Z","timestamp":1654009560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical findings and predictive factors for positive anti-interferon-\u03b3 autoantibodies in patients suffering from a non-tuberculosis mycobacteria or Talaromyces marneffei infection: a multicenter prospective cohort study"],"prefix":"10.1038","volume":"12","author":[{"given":"Ye","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianluan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"13160_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne, S. K. et al. Adult-onset immunodeficiency in Thailand and Taiwan. N. Engl. J. Med. 367, 725\u2013734 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"13160_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","volume":"71","author":"GH Hong","year":"2020","unstructured":"Hong, G. H. et al. Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States. Clin. Infect. Dis. 71(1), 53\u201362 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"13160_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10875-020-00869-5","volume":"41","author":"Y Qiu","year":"2021","unstructured":"Qiu, Y., Feng, X., Zeng, W., Zhang, H. & Zhang, J. Immunodeficiency disease spectrum in HIV-negative individuals with talaromycosis. J. Clin. Immunol. 41(1), 221\u2013223 (2021).","journal-title":"J. Clin. Immunol."},{"issue":"8","key":"13160_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","volume":"121","author":"CY Chi","year":"2013","unstructured":"Chi, C. Y. et al. Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood 121(8), 1357\u20131366 (2013).","journal-title":"Blood"},{"issue":"9","key":"13160_CR5","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/nm.4158","volume":"22","author":"CH Lin","year":"2016","unstructured":"Lin, C. H. et al. Identification of a major epitope by anti-interferon-\u03b3 autoantibodies in patients with mycobacterial disease. Nat. Med. 22(9), 994\u20131001 (2016).","journal-title":"Nat. Med."},{"issue":"10","key":"13160_CR6","doi-asserted-by":"publisher","first-page":"ofz208","DOI":"10.1093\/ofid\/ofz208","volume":"6","author":"W Zeng","year":"2019","unstructured":"Zeng, W. et al. Characterization of anti-interferon-\u03b3 antibodies in HIV-negative patients infected with disseminated Talaromyces marneffei and Cryptococcosis. Open Forum Infect. Dis. 6(10), ofz208 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"13160_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","volume":"72","author":"HP Shih","year":"2021","unstructured":"Shih, H. P., Ding, J. Y., Yeh, C. F., Chi, C. Y. & Ku, C. L. Anti-interferon-\u03b3 autoantibody-associated immunodeficiency. Curr. Opin. Immunol. 72, 206\u2013214 (2021).","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"13160_CR8","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","volume":"175","author":"SY Patel","year":"2005","unstructured":"Patel, S. Y. et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J. Immunol. 175(7), 4769\u20134776 (2005).","journal-title":"J. Immunol."},{"issue":"1","key":"13160_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145983","volume":"11","author":"N Chruewkamlow","year":"2016","unstructured":"Chruewkamlow, N. et al. Immune alterations in patients with anti-interferon-\u03b3 autoantibodies. PLoS ONE 11(1), e0145983 (2016).","journal-title":"PLoS ONE"},{"issue":"4","key":"13160_CR10","first-page":"311","volume":"19","author":"Li Dan","year":"2013","unstructured":"Dan, Li., Hui, X., Hua, L. & Yiming, S. Research progress in adult-onset immunodeficiency. Chin. J. AIDS STD. 19(4), 311\u2013313 (2013).","journal-title":"Chin. J. AIDS STD."},{"key":"13160_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"13160_CR12","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3389\/fimmu.2019.02473","volume":"10","author":"F Fenninger","year":"2019","unstructured":"Fenninger, F. et al. Mutation of an L-type calcium channel gene leads to T lymphocyte dysfunction. Front. Immunol. 10, 2473 (2019).","journal-title":"Front. Immunol."},{"issue":"1","key":"13160_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","volume":"9","author":"G Kak","year":"2018","unstructured":"Kak, G., Raza, M. & Tiwari, B. K. Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases. Biomol. Concepts 9(1), 64\u201379 (2018).","journal-title":"Biomol. Concepts"},{"issue":"25","key":"13160_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003927","volume":"95","author":"CY Chi","year":"2016","unstructured":"Chi, C. Y. et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine (Baltimore) 95(25), e3927 (2016).","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"13160_CR15","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1038\/s41598-021-95686-0","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu, Y. et al. Talaromyces marneffei and nontuberculous mycobacteria co-infection in HIV-negative patients. Sci. Rep. 11(1), 16177 (2021).","journal-title":"Sci. Rep."},{"issue":"4","key":"13160_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith, D. E. et al. An official ATS\/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175(4), 367\u2013416 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13160-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13160-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13160-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:48:42Z","timestamp":1669348122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13160-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13160-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"4 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9069"}}